News & Events
November 10, 2021
Register Now | RDCA-DAP Professional Webinar Series: RDCA-DAP Data Ingestion and Curation Process
In this month’s webinar, describes RDCA-DAP’s data management practices and use of ontologies, with an emphasis on how the data ingestion and curation processes increase the value of patients’ data.
October 27, 2021
View Now | RDCA-DAP Professional Webinar Series: RDCA-DAP Collaboration with Clinerion for Real World Data Solutions
In this webinar, Clinerion scientists will present an existing rare disease use case showcasing Clinerion predictive modeling efforts and discuss how collaboration with RDCA-DAP will leverage data from both platforms, improving the generalizability of such models. Audience discussion and Q&A will be included.
September 14, 2021
VIEW NOW | 2021 RDCA-DAP® WorkshopThe Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) is an FDA-funded initiative with the goal of accelerating therapy development across rare diseases. The platform serves as a centralized and standardized infrastructure to host and share rare diseases data, to support and accelerate rare disease innovation. View the RDCA-DAP 2021 Virtual Workshop and learn......
July 21, 2021
View Now | How RDCA-DAP Can Help Inform Optimal Trial Design in Progressive Rare Disease
When: July 21, 2021, 12 p.m. ET
Case Study: Northstar Ambulatory Assessment as an outcome assessment in Duchenne muscular dystrophy
Presenters: Varun Aggarwal, PhD, Director, Statistical and Mathematical Medicine, Quantitative Medicine; Kevin Krudys, PhD, Office of Clinical Pharmacology, FDA
RDCA-DAP team: Jeff Barrett, PhD, FCP, Senior Vice President, RDCA-DAP Lead; Alexandre Bétourné, PhD, PharmD, Scientific Director, RDCA-DAP
June 16, 2021
View Now | RDCA-DAP Webinar Series: Value of Integrated Data and Analytics in Rare Disease Drug Development
When: June 16, 2021, 12 p.m. ET
Case Study: Modeling disease progression in polycystic kidney disease to inform trial design
Presenters: Rhoda Muse, PhD, Scientist 1, Quantitative Medicine; Klaus Romero, MD, MS, FCP, Chief Science Officer and Executive Director of Clinical Pharmacology; Jackson Burton, PhD, Executive Director, Quantitative Medicine
RDCA-DAP Team: Jeff Barrett, PhD, FCP., Senior Vice President, RDCA-DAP Lead; Alexandre Bétourné, PhD, PharmD, Scientific Director, RDCA-DAP